期刊文献+

吉兰巴雷综合征患者急性期病情严重程度相关因素分析 被引量:2

Analysis on relevant factors of severity of Guillain-Barre syndrome during acute phase
在线阅读 下载PDF
导出
摘要 目的分析吉兰巴雷综合征(GBS)急性期临床、电生理及脑脊液特点,并探讨其病情进展严重程度的相关因素。方法回顾性分析2000年10月-2014年10月于长海医院就诊的GBS患者113例,根据患者高峰期Hughes评分划分病情等级,用Logistic回归模型分析病情严重程度与临床、电生理及脑脊液指标的相关性。结果急性期GBS患者年龄≥50岁(P=0.034,OR=14.702,95%CI:1.228-175.982)、脑脊液IgG增高(P=0.028,OR=26.652,95%CI:1.438-493.791)、周围神经轴索损害为主者(P=0.037,OR=48.529,95%CI:1.273-1850.656)更易发展为重型GBS。结论存在年龄≥50岁、脑脊液IgG增高、周围神经轴索损害的GBS患者病情相对较重,临床医生应针对此类患者提前实现个体化治疗。 Objective To analyze the clinical, electrophysiological and cerebrospinal characteristics of Guillain-Barre syndrome(GBS) during acute phase, and to explore the relevant factors of severity of progressive disease. Methods 113 patients with GBS admitted to Changhai Hospital from October 2000 to October 2014 were analyzed retrospectively.Hughes scale of fastigium was used to divide the illness level. Logistic regression model was used to analyze the correlation of severty of illness with clinical, electrophysiological and cerebrospinal indexes. Results Among the patients with GBS during acute phase, those whose age≥50 years old(P = 0.034, OR = 14.702, 95%CI: 1.228-175.982), increase of immunoglobulin G in cerebrospinal fluid(P = 0.028, OR = 26.652, 95%CI: 1.438-493.791), peripheral nerve neuraxon impairment(P = 0.037, OR = 48.529, 95%CI: 1.273-1850.656) were more likely to develop as severe GBS.Conclusion The state of patients with age≥50 years old, increase of immunoglobulin G in cerebrospinal fluid, peripheral nerve neuraxon impairment is more severe. Clinical doctors should realize individualized treatment in advance aiming at such patients.
出处 《中国医药导报》 CAS 2015年第11期93-96,100,共5页 China Medical Herald
关键词 吉兰巴雷综合征 病情严重程度 相关因素 Guillain-Barre syndrome Severty of illness Relevant factors
作者简介 通讯作者
  • 相关文献

参考文献17

  • 1Fokke C,van den Berg B,Drenthen J,et al. Diagnosis of Guillain-Barre syndrome and validation of Brighton crite- ria [J]. Brain:a journal of neurology,2014, 137(Pt 1) :33- 43.
  • 2Van den Berg B,Walgaard C,Drenthen J,et al~ Guillain-Barre syndrome : pathogenesis, diagnosis, treatment and progno- sis [J]. Nature Reviews Neurology,2014,10(8):469-482.
  • 3Van der Meche FG,Van Doom PA,Meulstee J,et al. Di- agnostic and classification criteria for the Guillain-Barre syndrome [J]. European neurology,2001,45(3): 133-139.
  • 4Hughes RA,Newsom-Davis JM,Perkin GD,et al. Con- trolled trial prednisolone in acute polyneuropathy [J]. Lancet, 1978,2(8093 ) : 750-753.
  • 5Kleyweg RP,van der Meche FG,Schmitz PI. Interobserver agreement in the assessment of muscle strength and func- tional abilities in Guillain-Barre syndrome [J]. Muscle & Nerve, 1991,14(11) : 1103-1109.
  • 6Kuwabara S,Yuki N. Axonal Guillain-Barre syndrome: concepts and controversies [J]. The Lancet Neurology, 2013,12( 12) : 1180-1188.
  • 7李元,王爱民,唐红宇,欧阳松,段维维,王未飞.吉兰-巴雷综合征急性期病情严重程度及预测因素分析[J].中国神经免疫学和神经病学杂志,2014,21(4):265-268. 被引量:13
  • 8Van Koningsveld R, Van Doom PA, Schmitz PI,et al. Mild forms of Guillain-Barre syndrome in an epidemiologic sur- vey in The Netherlands [J]. Neurology, 2000,54 (3) : 620- 625.
  • 9Chio A,Cocito D,Leone M,et al. Guillain-Barre syn- drome : a prospective, population-based incidence and out- come survey [J]. Neurology, 2003,60 (7) : 1146-1150.
  • 10Lyu RK,Tang LM,Cheng SY,et ai. Guillain-Barre syn- drome in Taiwan:a clinical study of 167 patients [J]. Jour- nal of neurology,neurosurgery,and psychiatry, 1997,63 (4) :494-500.

二级参考文献21

  • 1林超萍,陈桂山.急性化脓性脑膜炎血脑屏障与IgG、IgG指数变化的研究[J].国际医药卫生导报,2003,9(18):70-71. 被引量:2
  • 2郑昆文,赵重波.散发性脑炎脑脊液免疫球蛋白G指数和血脑屏障的变化[J].中国综合临床,2004,20(10):884-885. 被引量:1
  • 3沈霞.中枢神经系统疾病的免疫学检验[J].检验医学,2006,21(4):434-436. 被引量:17
  • 4van Koningsveld R, Schmitz PI, Ang CW, et al. Infections and course of disease in mild forms of Guillain-Barré syndrome. Neurology, 2002,58:610-614.
  • 5van Koningsveld R, van Doorn PA, Schmitz PI, et al. Mild forms of Guillain-Barré syndrome in an epidemiologic survey in the Netherlands. Neurology, 2000,54:620-625.
  • 6Green DM, Ropper AH. Mild Guillain-Barré Syndrom. Arch Neurol, 2001,58:1098-1101.
  • 7Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol, 2001,58:893-898.
  • 8Ho DW, Mishu B, Li CY, et al. Guillain-Barré syndrom in northern China.Relationship to Campylobacer jejuni infection and anti-glycolipid antibodies. Brain, 1995,118:597-605.
  • 9van der Meche FG, van Doorn PA,et al. Diagnosis and classification criteria for the Guillain-Barré syndrome. Eur Neurol, 2001,45:133-139.
  • 10Hughes RA, Newsom-Davis JM, Perkin GD, et al. Controlled trial of prednisolone in acute polyneuropathy. Lancet, 1978,2:750-753.

共引文献33

同被引文献12

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部